Kineta Immuno-Oncology, LLC — Form D
Kineta Immuno-Oncology, LLC of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-12. The offering totals $1.5M, of which $238K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-08-12
- Form: D
- Accession: 0001682247-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $238K
- Remaining: $1.3M
- Minimum investment: $25K
- Investors: 6
- Date of first sale: 2016-08-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-268881
Issuer
- Name: Kineta Immuno-Oncology, LLC
- CIK: 0001682247
- Entity type: Limited Liability Company
- Jurisdiction: WASHINGTON
- Incorporated: 2016
- Address: 219 TERRY AVENUE N., SEATTLE, WA, 98109-5208
- Phone: 206-378-0400
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Shawn Iadonato | Director | Seattle, WA |
| Shawn Iadonato | Executive Officer | Seattle, WA |
| Robert Hedequist | Executive Officer | Seattle, WA |
Other filings by this issuer (2)
More